ESPR FY 2014 Earnings — Esperion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ESPREsperion Therapeutics, Inc.

$512M

FY 2014 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$36M

Net Income

-$36M

EPS (Diluted)

$-2.22

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$33M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$143M

Total Liabilities

$10M

Stockholders' Equity

$134M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$5.0B	-100.0%
Gross Profit	$0	$5.0B	-100.0%
Operating Income	-$36M	-$23M	-59.2%
Net Income	-$36M	-$26M	-39.4%